Zhuhai Rundu Pharmaceutical Co Ltd Class A (002923) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.036x

Based on the latest financial reports, Zhuhai Rundu Pharmaceutical Co Ltd Class A (002923) has a cash flow conversion efficiency ratio of 0.036x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥37.78 Million ≈ $5.53 Million USD) by net assets (CN¥1.05 Billion ≈ $153.24 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See 002923 days of operational coverage to measure how many days the company can operate on defensive assets alone.

Zhuhai Rundu Pharmaceutical Co Ltd Class A - Cash Flow Conversion Efficiency Trend (2011–2024)

This chart illustrates how Zhuhai Rundu Pharmaceutical Co Ltd Class A's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Zhuhai Rundu Pharmaceutical Co Ltd Class A Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Zhuhai Rundu Pharmaceutical Co Ltd Class A ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Shenzhen Jinxinnong Feed Co Ltd SHE:002548	-0.071x
Summit Hotel Properties Inc NYSE:INN	0.035x
Taier Heavy Industry Co Ltd SHE:002347	-0.014x
Haixia Envrnmnt SHG:603817	0.015x
Yonker Environmental Protect SHE:300187	0.097x
Nanjing Well Pharmaceutical Co Ltd SHG:603351	0.039x
Irish Residential Properties IR:IRES	0.019x
First Foundation Inc. NYSE:FFWM	-0.027x

Annual Cash Flow Conversion Efficiency for Zhuhai Rundu Pharmaceutical Co Ltd Class A (2011–2024)

The table below shows the annual cash flow conversion efficiency of Zhuhai Rundu Pharmaceutical Co Ltd Class A from 2011 to 2024. For the full company profile with market capitalisation and key ratios, see Zhuhai Rundu Pharmaceutical Co Ltd Class (002923) total market value.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	CN¥1.15 Billion ≈ $168.59 Million	CN¥211.19 Million ≈ $30.90 Million	0.183x	+25.17%
2023-12-31	CN¥1.18 Billion ≈ $172.55 Million	CN¥172.68 Million ≈ $25.27 Million	0.146x	+29.73%
2022-12-31	CN¥1.20 Billion ≈ $175.01 Million	CN¥135.01 Million ≈ $19.76 Million	0.113x	-39.03%
2021-12-31	CN¥1.11 Billion ≈ $162.74 Million	CN¥205.91 Million ≈ $30.13 Million	0.185x	-23.22%
2020-12-31	CN¥1.04 Billion ≈ $151.93 Million	CN¥250.35 Million ≈ $36.63 Million	0.241x	+49.86%
2019-12-31	CN¥940.29 Million ≈ $137.59 Million	CN¥151.30 Million ≈ $22.14 Million	0.161x	-11.85%
2018-12-31	CN¥871.29 Million ≈ $127.50 Million	CN¥159.04 Million ≈ $23.27 Million	0.183x	+53.97%
2017-12-31	CN¥488.84 Million ≈ $71.53 Million	CN¥57.95 Million ≈ $8.48 Million	0.119x	-49.82%
2016-12-31	CN¥398.19 Million ≈ $58.27 Million	CN¥94.07 Million ≈ $13.77 Million	0.236x	+46.41%
2015-12-31	CN¥310.72 Million ≈ $45.47 Million	CN¥50.14 Million ≈ $7.34 Million	0.161x	-23.98%
2014-12-31	CN¥273.31 Million ≈ $39.99 Million	CN¥58.01 Million ≈ $8.49 Million	0.212x	+58.34%
2013-12-31	CN¥236.29 Million ≈ $34.58 Million	CN¥31.67 Million ≈ $4.63 Million	0.134x	-61.82%
2012-12-31	CN¥199.43 Million ≈ $29.18 Million	CN¥70.01 Million ≈ $10.25 Million	0.351x	+72.18%
2011-12-31	CN¥165.33 Million ≈ $24.19 Million	CN¥33.71 Million ≈ $4.93 Million	0.204x	--

About Zhuhai Rundu Pharmaceutical Co Ltd Class A

SHE:002923 China Drug Manufacturers - Specialty & Generic

Market Cap

$489.56 Million

CN¥3.35 Billion CNY

Market Cap Rank

#12567 Global

#3738 in China

Share Price

CN¥9.99

Change (1 day)

-1.58%

52-Week Range

CN¥9.89 - CN¥17.35

All Time High

CN¥20.52